EnsoData, AI Healthcare Company and Maker of EnsoSleep, and LabRetriever™, Sleep EMR and Time Savings Provider, Announce Partnership
Press Releases
Jun 05, 2019
MADISON, Wis., June 5, 2019 /PRNewswire/ — EnsoData, a healthcare artificial intelligence company and maker of FDA-cleared EnsoSleep, publicly announced Tuesday a partnership with LabRetriever [sleep EMR]. The partnership brings together two cutting-edge medical software solutions tailored to sleep clinicians’ needs – saving them time, increasing clinic efficiency, and opening up opportunities for increased revenue.
LabRetriever, sleep EMR is a comprehensive software solution offering physicians greater workflow efficiencies, improved and automated communications, increased bed utilization, and easy management of patient information. Serving as a perfect complement to the LabRetriever suite, EnsoSleep helps clinicians reduce time spent scoring in-lab and home sleep studies by fifty percent or more without sacrificing quality. Since 2017, clinicians from more than 250 sleep clinic customers have used EnsoSleep AI scoring to analyze their sleep studies, saving thousands of hours every month.
LabRetriever and EnsoData have already collaborated to bring their services to shared clients with strong results and outcomes since 2018, and the partnership will support a quick and seamless rollout to sleep labs interested in multiplying their time-savings with the complimentary products.
“After working with the LabRetriever team to onboard several shared customers, it was a no-brainer to establish an easy way for all sleep clinics to benefit. Through the launch of this partnership, a clinic using LabRetriever can try out EnsoSleep, literally at the flip of a switch. EnsoSleep users have loved the ‘zero-click’ workflow that effortlessly provides fast, quality scoring. Now, those time-savings are even easier to realize, with our ‘zero-install’ AI scoring provided directly within existing LabRetriever cloud workflows and available to every user,” said Chris Fernandez, CEO and Co-founder of EnsoData.
“LabRetriever and EnsoSleep are powerful and effective tools for labs working hard to keep up with the increasing volume of home sleep studies, the growing shortage of clinicians, and the pressure on reimbursements,” said Cheryl Harner, COO of LabRetriever. “I am excited to help provide sleep clinics a level of efficiency that allows them not just to survive but to thrive in this changing sleep environment.”
About EnsoData
EnsoData (www.ensodata.com) provides artificial intelligence based software-as-a-service that automates complex, arduous, and time-consuming data analysis for frontline clinicians. Their first product, EnsoSleep, is FDA cleared and automates the scoring of in-lab and home sleep studies, and aids clinicians in the diagnosis of sleep disorders like sleep apnea.
About Lab Retriever
Designed for single-site to enterprise class laboratory networks, LabRetriever provides the most flexible and fully-customizable sleep lab management software solution in the industry. Users can efficiently manage patient scheduling, referrals, physician review, reporting, communications, HST workflow, and device management securely at any time and from anywhere. Visit www.mylabretriever.com for more information or contact them at solutions@mylabretriever.com.
For more information about EnsoData, visit www.ensodata.com and download our new whitepaper
Media Contact:
Chris Fernandez
608-509-4704
215947@email4pr.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/ensodata-ai-healthcare-company-and-maker-of-ensosleep-and-labretriever-sleep-emr-and-time-savings-provider-announce-partnership-300862558.html
SOURCE EnsoData